US Patent 7241618 Expression system
Patent 7241618 was granted and assigned to Cancer Research Technology Limited on July, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Reuven Agami0
Thijn Brummelkamp0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+406 characters)
Article
Patent abstract
The present invention provides a polynucleotide comprising a RNA polymerase III promoter, a region encoding a siRNA, and a transcriptional termination element comprising five consecutive thymine residues. The invention also provides for vectors, cells and non-human transgenic animal comprising the polynucleotides of the invention as well as their use in medicaments for various conditions.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07241618 Expression system US Patent 7241618 Expression system
Infobox
Patent Number
072416180
Patent Number
72416180
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072416180
Date of Patent
July 10, 2007
0Patent Application Number
103241840
Date Filed
December 19, 2002
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07241618 Expression system
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07241618
Date of patent
July 10, 2007
Patent application number
10324184
Date Filed
December 19, 2002
Patent primary examiner
Find more entities like US Patent 7241618 Expression system
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.